Novitero For Profit
Novitero primarily engages in the design and development of drugs for cancer treatment. Through its computational drug discovery technology platform, Novitero design drugs specifically for human tumors. These drugs includ Gleevec, Irresa, and Zelboraf.
Headquarters:
Ness Ziona, HaMerkaz, Israel
Founded Date:
2014
Industry:
Clinical Data Management
Technology:
Drug development